ID: ALA243040

Max Phase: Preclinical

Molecular Formula: C22H21N3O2

Molecular Weight: 359.43

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN(C(N)=O)c1ccc(OCCn2c3ccccc3c3ccccc32)cc1

Standard InChI:  InChI=1S/C22H21N3O2/c1-24(22(23)26)16-10-12-17(13-11-16)27-15-14-25-20-8-4-2-6-18(20)19-7-3-5-9-21(19)25/h2-13H,14-15H2,1H3,(H2,23,26)

Standard InChI Key:  VJJDHXRWHRJNNY-UHFFFAOYSA-N

Associated Targets(non-human)

RAW 181 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 359.43Molecular Weight (Monoisotopic): 359.1634AlogP: 4.39#Rotatable Bonds: 5
Polar Surface Area: 60.49Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.73CX LogD: 3.73
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.57Np Likeness Score: -1.03

References

1. Kim YJ, Ryu JH, Cheon YJ, Lim HJ, Jeon R..  (2007)  Design and synthesis of urea and thiourea derivatives and their inhibitory activities on lipopolysaccharide-induced NO production.,  17  (12): [PMID:17467989] [10.1016/j.bmcl.2007.04.005]

Source